Physician profile
Manmohan Singh
NPI 1609262864
$2,645.75
in general payments reported to CMS, 2019-2025
21 companies · $78.96 in 2025
The $78.96 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $195 · 2021: $345 · 2022: $997 · 2023: $793 · 2024: $51.62 · 2025: $78.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562 · Education: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.85 |
| Education | $361.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $394.44 | 2022-2023 | Crosser Iq |
| Medtronic, INC. | $272.40 | 2021-2025 | Corevalve Evolut R, Venaseal |
| Terumo Medical Corporation | $269.39 | 2022-2023 | Navicross, Glidewire, Angio-Seal |
| Amgen INC. | $269.26 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.31 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $215.31 | 2020-2023 | Wolverine Coronary Cutting Balloon |
| Inari Medical, INC. | $176.92 | 2022 | |
| Abbott Laboratories | $173.08 | 2022 | |
| Novo Nordisk INC | $114.82 | 2022 | |
| Biotronik INC. | $91.04 | 2021 | |
| Pfizer INC. | $87.01 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $76.28 | 2019-2022 | |
| Philips North America LLC | $70.00 | 2023 | |
| Akcea Therapeutics, INC. | $40.26 | 2020 | |
| Sobi, INC | $36.76 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $23.85 | 2020 | |
| Shire North American Group INC | $15.04 | 2019 | |
| Cardiva Medical, INC. | $14.33 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $13.30 | 2022 | |
| Medtronic Vascular, INC. | $12.97 | 2020 | |
| Cardiovascular Systems INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manmohan Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.